Gemcitabine Sensitivity is Improved in Pancreatic Cancer by CYR61/CCN1-Depletion-Mediated Upregulation of dCK and Suppression of CTGF

被引：0
|
作者：
Ghosh, Arnab
Maity, Gargi
Gupta, Vijaylaxmi
Haque, Inamul
Sarkar, Sandipto
Das, Amlan
Dhar, Kakali
Bhavanasi, Sneha
Gunewardena, Sumedha S.
Von Hoff, Daniel D.
Mallik, Sanku
Kambhampati, Suman
Banerjee, Sushanta
Banerjee, Snigdha
机构：
来源：
FASEB JOURNAL | 2019年 / 33卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
647.8
引用
收藏
页数：3
相关论文
共 50 条
  • [1] CCN1/Cyr61 regulation of gemcitabine-resistant phenotype in pancreatic cancer: involvement of CTGF and dCK
    Gupta, Vijayalaxmi G.
    Maity, Gargi
    Haque, Inamul
    Banerjee, Sushanta K.
    Banerjee, Snigdha
    CANCER RESEARCH, 2017, 77
  • [2] CYR61/CCN1 Regulates dCK and CTGF and Causes Gemcitabine-resistant Phenotype in Pancreatic Ductal Adenocarcinoma
    Maity, Gargi
    Ghosh, Arnab
    Gupta, Vijayalaxmi
    Haque, Inamul
    Sarkar, Sandipto
    Das, Amian
    Dhar, Kakali
    Bhavanasi, Sneha
    Gunewardena, Sumedha S.
    Von Hoff, Daniel D.
    Mallik, Sanku
    Kambhampati, Suman
    Banerjee, Sushanta K.
    Banerjee, Snigdha
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (04) : 788 - 800
  • [3] CCN1 (CYR61): Two faces in cancer
    不详
    JOURNAL OF CLINICAL PATHOLOGY, 2005, 58 (05) : 473 - 474
  • [4] Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer
    Jiang, WG
    Watkins, G
    Fodstad, O
    Douglas-Jones, A
    Mokbel, K
    Mansel, RE
    ENDOCRINE-RELATED CANCER, 2004, 11 (04) : 781 - 791
  • [5] Zoledronic acid-induced suppression of invasive phenotypes of pancreatic cancer cells is mediated through downregulation of CYR61/CCN1
    Ghosh, Arnab
    Sarkar, Sandipto
    Ghosh, Sonia
    Ray, Priyanka
    Quadir, Mohi
    Banerjee, Sushanta K.
    Banerjee, Snigdha
    CANCER RESEARCH, 2019, 79 (13)
  • [6] Differential expression of CYR61, CTGF and NOV in pancreatic cancer and the clinical relevance
    Ji, K.
    Li, J.
    Gao, X.
    Hao, C. Y.
    Ji, J.
    Jiang, W.
    Ye, L.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S404 - S405
  • [7] Cyr61/CCN1 regulates SHh through Notch signaling in pancreatic cancer cells
    Haque, Inamul
    Majumder, Monami
    Banerjee, Sushanta K.
    Mehta, Smita
    Banerjee, Snigdha
    CANCER RESEARCH, 2012, 72
  • [8] Increased expression of Cyr61 (CCN1) identified in peritoneal metastases from human pancreatic cancer
    Holloway, SE
    Beck, AW
    Girard, L
    Jaber, MR
    Barnett, CC
    Brekken, RA
    Fleming, JB
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2005, 200 (03) : 371 - 377
  • [9] Caught between a "Rho" and a hard place: are CCN1/CYR61 and CCN2/CTGF the arbiters of microvascular stiffness?
    Chaqour, Brahim
    JOURNAL OF CELL COMMUNICATION AND SIGNALING, 2020, 14 (01) : 21 - 29
  • [10] The matrix protein CCN1/CYR61 is required for ανβ5-mediated cancer cell migration
    Jandova, Jana
    Beyer, Tracey E.
    Meuillet, Emmanuelle J.
    Watts, George S.
    CELL BIOCHEMISTRY AND FUNCTION, 2012, 30 (08) : 687 - 695
12345